skip to Main Content

EVENT BIO

See breakdown of all you need to know about our Summit

HOT CONFERENCE TOPICS

  • Navigating through PV inspections – from announcement to CAPA
  • Latest trends in Adverse Event Reporting from Social Media
  • Implementation of GVP Rev 2 – Actual experience
  • Multi Criteria Decision Analysis in drug development – practical examples from a development program
  • Could be Pharmacovigilance considered as a thermometer for business?
  • Enhanced EudraVigilance System – future perspectives
  • Benefit-risk evaluation of anticancer medicinal products at entry into human in a changing environment: a review of EMA/CHMP/205/95 Rev.5 guideline
  • Quantitative benefit-risk assessment and patient centricity
  • Patient Support Programmes and Market Research from PV standpoint

WHO WILL YOU MEET

Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors, QPPVs, and Heads of departments from pharmaceutical industry / industries involved in:

  • Pharmacovigilance
  • Drug Safety
  • Safety & Risk Management
  • Signal Detection
  • Benefit-Risk Assessment
  • Safety Evaluation
  • Regulatory Affairs, Pharmacovigilance
  • PV Governance
  • Safety Surveillance
  • Pharmacovigilance Operations
  • PV Inspection and Audit Readiness
  • Patient Support Programs
  • Market Research Programs
  • Clinical Safety
  • Medical Safety
  • Medical Information
  • Pharmacoepidemiology

Workshop A
18 September 2018 I 15.00 – 16.00

Digital Pharmacovigilance

  • Digital Media to complement the current safety systems for evaluating medicines
  • Mobile Technologies and Social Media in Pharmacovigilance
  • Facebook and Twitter monitoring to detect safety signals for medical products
  • Practical examples of social listening in Pharma
  • Digital Pharmacovigilance and disease surveillance: Combining traditional and Big-Data systems for better public health
  • Limitations in social media reporting – Maintaining patient´s privacy and confidentiality

Workshop B
18 September 2018 I 16.00 – 17.00

Artificial Intelligence and Machine Learning in Drug Safety

  • AI-based web and social monitoring – how can companies reliably and efficiently achieve a complete digital vigilance?
  • Automation in Pharmacovigilance Data Processing – Do You Trust Artificial Intelligence?
  • What is the organizational impact of transformation to automation in PV?
  • The usage of wearable devices in pharmacovigilance
  • Taking the next-generation approach to risk management
  • Incorporation of new technologies in global pharmacovigilance

WHAT DELEGATES SAID

5th Annual Risk Management and Pharmacovigilance Summit
will start in
TIME IS RUNNING OUT! DON’T RISK MISSING IT
Back To Top